Novo Nordisk's CEO Mike Doustdar said the Danish pharma company is open to a direct listing on the New York Stock Exchange, which would replace its current American depositary receipt (ADR) structure. However, the company is not actively pursuing this change now, keeping it as a future option. The move would allow US investors to buy shares directly on the NYSE rather than through ADRs. Shares dropped over 2% following the announcement, while Novo Nordisk also outlined plans to diversify and expand its drug pipeline by 2030.
Novo Nordisk shares are trading at USD 38.28 on Pluang as of Sep 24, 2026 01:03 WIB, down 2.84% in the last day. The stock's market cap stands at $175.28 billion, reflecting its significant size in the health sector. On Pluang, 89% of order activity is buying, indicating strong investor interest despite recent price declines.
Novo's drug CagriSema has demonstrated a significant 25% weight loss effect in women, a promising result that could boost the company's prospects. This development is important as it may help revive investor confidence and improve the company's stock...
OpenAI has acquired Orchestra Bio, a four-year-old AI biotech startup that develops software to assist biotech firms in managing drug discovery tasks such as finances and clinical trial scheduling. The acquisition aims to integrate Orchestra's techno...
Eli Lilly's stock rose 4% following a positive recommendation from the European Medicines Agency for its oral obesity pill, Foundayo, which is now close to final approval in the EU. This pill offers dosing flexibility and treats both weight managemen...
Novo Nordisk's experimental obesity drug CagriSema demonstrated an average 25% weight loss among adult women after 68 weeks in a new analysis following a late-stage trial. The drug, combining semaglutide and cagrilintide, also showed significant weig...
Eli Lilly reported strong Q2 earnings with revenue up 47.67% and EPS beating estimates, driven by high sales of its obesity drug Mounjaro. The company raised its 2026 revenue guidance to $85-$87 billion and is optimistic about the upcoming U.S. filin...
